Author

I. Haviv

Observed names: I Haviv, I. HAVIV, Izhac Haviv

Institutions: Bar-Ilan University, The University of Melbourne

Observed institutions: Mayo Clinic, Bar-Ilan University, Baker Heart and Diabetes Institute, The University of Melbourne, QIMR Berghofer Medical Research Institute, Peter MacCallum Cancer Centre, Queen Giovanna Hospital, UNSW Sydney, Kitov Pharmaceuticals (Israel), Data61, St John of God Health Care, Weizmann Institute of Science

OpenAlex ID: A5111805627

Plasma Lipid Profiling Shows Similar Associations with Prediabetes and Type 2 Diabetes

2013 · Peter J. Meikle, Gerard Wong, et al. · PLoS ONE · 308

PDF

Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma

2018 · Olga Kondrashova, Monique Topp, et al. · Nature Communications · 296

PDF

Prognostic gene expression signature for high-grade serous ovarian cancer

2020 · J. Millstein, T. Budden, et al. · Annals of Oncology · 155

PDF

Deep microbial analysis of multiple placentas shows no evidence for a placental microbiome

2019 · AA Kuperman, A Zimmerman, et al. · BJOG An International Journal of Obstetrics & Gynaecology · 141

pX, the HBV‐encoded coactivator, interacts with components of the transcription machinery and stimulates transcription in a TAF‐independent manner.

1996 · I. Haviv, D. Vaizel, et al. · The EMBO Journal · 100

The social aspects of EMT-MET plasticity

2011 · E W Thompson, I Haviv · Nature Medicine · 86

Transcriptional repression by the C-terminal domain of p53.

1995 · E Shaulian, I Haviv, et al. · PubMed · 60

Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses

2020 · Eun Young Kang, Dane Cheasley, et al. · Modern Pathology · 42

PDF

BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance

2024 · Ksenija Nesic, John J. Krais, et al. · Molecular Cancer · 36

PDF

MyD88 and TLR4 Expression in Epithelial Ovarian Cancer

2018 · Matthew S. Block, Robert A. Vierkant, et al. · Mayo Clinic Proceedings · 31

PDF

BRCA mutations and outcome in epithelial ovarian cancer (EOC): experience in ethnically diverse groups

2013 · T. Safra, W.C. Lai, et al. · Annals of Oncology · 31

PDF

pX, the HBV-encoded coactivator, suppresses the phenotypes of TBP and TAFII250 mutants

1998 · I. Haviv, Y. Matza, et al. · Genes & Development · 31

PDF

Opposing effects of monomeric and pentameric C-reactive protein on endothelial progenitor cells

2011 · I. Ahrens, H. Domeij, et al. · Basic Research in Cardiology · 27

PDF

Increased COX-2 expression in epithelial and stromal cells of high mammographic density tissues and in a xenograft model of mammographic density

2015 · G. L. Chew, C. W. Huo, et al. · Breast Cancer Research and Treatment · 20

Effects of Tamoxifen and oestrogen on histology and radiographic density in high and low mammographic density human breast tissues maintained in murine tissue engineering chambers

2014 · G. L. Chew, C. W. Huo, et al. · Breast Cancer Research and Treatment · 17

Timing of whole genome duplication is associated with tumor-specific MHC-II depletion in serous ovarian cancer

2024 · Nikki L. Burdett, Madelynne O. Willis, et al. · Nature Communications · 16

PDF

High and low mammographic density human breast tissues maintain histological differential in murine tissue engineering chambers

2012 · G. L. Chew, D. Huang, et al. · Breast Cancer Research and Treatment · 14

PDF

Dynamic changes in high and low mammographic density human breast tissues maintained in murine tissue engineering chambers during various murine peripartum states and over time

2013 · G. L. Chew, D. Huang, et al. · Breast Cancer Research and Treatment · 13

PDF

Small-scale mutations are infrequent as mechanisms of resistance in post-PARP inhibitor tumour samples in high grade serous ovarian cancer

2023 · Nikki L. Burdett, Madelynne O. Willis, et al. · Scientific Reports · 6

PDF

Current and potential uses for DNA microarrays in transplantation medicine: lessons from other disciplines

2003 · A. Boussioutas, I. Haviv · Tissue Antigens · 4

Regulation of inflammatory gene expression by histone acetylation and HDAC inhibition in human aortic endothelial cells

2015 · H. Rafehi, A. Balcerczyk, et al. · Atherosclerosis · 3

Determining epithelial contribution to in vivo mesenchymal tumour expression signature using species-specific microarray profiling analysis of xenografts

2013 · E. PURDOM, C. RESTALL, et al. · Genetics Research · 2

PDF

631 Androstenedione Is the Most Efficient Precursor of Intraprostatic Testosterone Production in Primary Human Prostate Cancer Tissue

2011 · M. Fankhauser, N. Amiry, et al. · European Urology Supplements · 1

A Phase I/II, Open-Label, Dose Escalation Followed by Single-Arm Expansion to Assess the Safety and Efficacy of NT219 in Combination with Cetuximab in Patients with Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC)

2020 · O. Ronen, M. Shickler, et al. · International Journal of Radiation Oncology*Biology*Physics

Hepatitis C virus leaves epigenetic signature post cure by direct-acting antivirals that is linked to distinct mutation signature

2018 · M. Gal-Tanamy, S. Perez, et al. · Journal of Hepatology

Works count: 36

Citation count: 1,439

H-index: 16

I10-index: 18